Background:
To investigate the effect of C-reactive protein on the activated partial thromboplastin time (APTT) (different activators) in different detecting systems.
Methods:
The C-reactive protein and coagulation test of 112 patients with the infectious disease were determined by automation protein analyzer IMMAG 800 and automation coagulation analyzer STA-R Evolution, respectively. The pooled plasma APTT with different concentrations of C-reactive protein was measured by different detecting system: STA-R Evolution (activator: silica, kaolin), Sysmex CS-2000i (activator: ellagic acid), and ACL TOP 700 (activator: colloidal silica). In addition, the selfmade platelet lysate (phospholipid) was added to correct the APTT prolonged by C-reactive protein (150 mg/L) on STA-R Evolution (activator: silica) system.
Results:
The good correlation between C-reactive protein and APTT was found on the STA-R Evolution (activator: silica) system. The APTT on the STA-R Evolution (activator: silica) system was prolonged by 24.6 second, along with increasing C-reactive protein concentration. And the APTT of plasma containing 150 mg/L C-reactive protein was shortened by 3.4-6.9 second when the plasma was mixed with self-made platelet lysate. However, the APTT was prolonged unobviously on other detecting systems including STA-R Evolution (activator: kaolin), Sysmex CS-2000i, and ACL TOP 700.
Conclusion: C-reactive protein interferes with the detection of APTT, especially in STA-R Evolution (activator: silica) system. The increasing in C-reactive protein results in a false prolongation of the APTT (activator: silica), and it is most likely that Creactive protein interferes the coagulable factor binding of phospholipid.
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| Subjects

| Preparation of pool plasma
| Instruments and reagents
| Preparation of phospholipid (the lysate of thrombocytes)
Blood from 10 healthy individuals was drawn into vacuum tube containing 0.109 M sodium citrate, then centrifuging at 200 × g 10 minutes for 2 times and isolating platelet-rich plasma (PRP). 1 The PRP was centrifuged at 1500 × g 10 minutes under 4°C to get sediments that contain enrichment platelet, and the pillet in Eppendorf Tube was repeatedly refrozen and thawed more than 5 times manually, and stored at −80°C until analysis.
| Experimental methods
The serums of 112 patients were measured by an immunoturbidimetric assay on IMMAG 800, and the APTT, PT, FIB, and TT were detected on automation coagulator STA-R Evolution (activator: silica). Purified CRP was added into the pool plasma, and gained terminal concentrations 
| Statistics analysis
Statistical analysis was performed by SPSS 22.0 software. The relation between APTT and CRP was analyzed by linear regression analysis and t test. P < .05 was considered as statistical significance.
| RE SULTS
| The relationship between CRP and APTT (activator: silica)
Along with increasing CRP concentrations, APTT detected on STA-R Evolution (activator: silica) had a tendency to extend, while PT, FIB, and TT had no obvious change in 112 patients involved in this study (Figure 1 ).
| The pooled plasma APTTs measured in the four systems
The four different systems were used to detect APTT of the same original plasma orderly. Surprisingly, APTTs were 34.5 second, 30.7
F I G U R E 1 Correlation between CRP and APTT (activator: silica) among the 112 patients second, 30.6 second and 37.7 second, which were significantly different (Table 1) 
| Phospholipids corrected the prolonged APTT
Subsequently, to verify whether CRPs interfere with the phospholipid that come from ATPP reagents, different dilution ratio of the lysate of thrombocyte (self-made phospholipids) was added into the mixed plasma to correct APTT which prolonged by C-reactive protein (150 mg/L) on STA-R Evolution (activator: silica; Table 2 ). As shown in Figure 3 , the APTTs of the plasma shortened by 3.4-6.9 second. 
| D ISCUSS I ON
